flebogamma 10% dif normal immunoglobulin (human) 20g/200ml intravenous use injection vial
grifols australia pty ltd - normal immunoglobulin, quantity: 20 g - injection, solution - excipient ingredients: human immunoglobulin a; water for injections; sorbitol - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation indications: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count. - guillain barr? syndrome - kawasaki disease.
flebogamma 10% dif normal immunoglobulin (human) 10g/100ml intravenous use injection vial
grifols australia pty ltd - normal immunoglobulin, quantity: 10 g - injection, solution - excipient ingredients: human immunoglobulin a; water for injections; sorbitol - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.,immunomodulation indications: - idiopathic thrombocytopaenic purpura (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count. - guillain barr? syndrome - kawasaki disease.
xembify normal immunoglobulin 10 g/50 ml (20%) solution for subcutaneous injection vial
grifols australia pty ltd - human immunoglobulin g, quantity: 9000 mg - solution - excipient ingredients: glycine; polysorbate 80; water for injections - indications for subcutaneous administration (scig),xembify? is indicated as replacement therapy in adult and paediatric patients for:,- primary immunodeficiency diseases (pid),- symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
xembify normal immunoglobulin 1 g/5 ml (20%) solution for subcutaneous injection vial
grifols australia pty ltd - human immunoglobulin g, quantity: 900 mg - solution - excipient ingredients: glycine; polysorbate 80; water for injections - indications for subcutaneous administration (scig),xembify? is indicated as replacement therapy in adult and paediatric patients for:,- primary immunodeficiency diseases (pid),- symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
xembify normal immunoglobulin 4 g/20 ml (20%) solution for subcutaneous injection vial
grifols australia pty ltd - human immunoglobulin g, quantity: 3600 mg - solution - excipient ingredients: glycine; polysorbate 80; water for injections - indications for subcutaneous administration (scig),xembify? is indicated as replacement therapy in adult and paediatric patients for:,- primary immunodeficiency diseases (pid),- symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
xembify normal immunoglobulin 2 g/10 ml (20%) solution for subcutaneous injection vial
grifols australia pty ltd - human immunoglobulin g, quantity: 1800 mg - solution - excipient ingredients: glycine; polysorbate 80; water for injections - indications for subcutaneous administration (scig),xembify? is indicated as replacement therapy in adult and paediatric patients for:,- primary immunodeficiency diseases (pid),- symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
veraseal solutions for sealant 2 ml (human fibrinogen 80 mg/ml syringe 1 ml / human thrombin 500 iu/ml syringe 1 ml)
grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.
veraseal solutions for sealant 10 ml (human fibrinogen 80 mg/ml syringe 5 ml / human thrombin 500 iu/ml syringe 5 ml)
grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.
veraseal solutions for sealant 4 ml (human fibrinogen 80 mg/ml syringe 2 ml / human thrombin 500 iu/ml syringe 2 ml)
grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.
veraseal solutions for sealant 6 ml (human fibrinogen 80 mg/ml syringe 3 ml / human thrombin 500 iu/ml syringe 3 ml)
grifols australia pty ltd - human thrombin, quantity: 500 iu/ml - application - excipient ingredients: - veraseal is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.